Oniria Therapeutics
Barcelona · Founded 2021
About Oniria Therapeutics
Onira Therapeutics is modifying cell dormancy to fight the persistence of cancer.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.7M
- Funding stage: Seed
- Last round: Grant (May 2025)
- Website: https://www.oniriatherapeutics.com
- Phone: +34 620 006 316
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oniria-therapeutics-4176 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.